IRDNasdaqPharmaceutical Preparations

Opus Genetics, Inc. (IRD) earnings date, market-implied expected move, and options open interest by expiry

4.13

+0.20 · +5.09%

Regular session11:01 ET

Open3.95Volume1.1MMkt cap$327.0MEPS-1.27

Day3.95 – 4.1497%52-wk1.70 – 7.0745%

IRD

Opus Genetics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 11

before open · in 7 days

est.Q3 FY26

Calendar

Next report

Last report

−1.59%

vs ±41.2% implied · ×0.04

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

5dVTRS · supplierViatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.

News

Largest filed tie

13F top-10 QoQ

+27.37%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

103 managers

Top fund weight

0.01%

IRD weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Opus Genetics (IRD) is expected to report on Nov 11 before open (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 6 '26confirmed±41.2%▼−1.59%×0.04

quarterimplied−45%0+45%realized×

Q2 FY26±41.2%▼−1.59%×0.04

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 16 close

0.01OI · 3 expiries · Oct 16 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

750%Nov 2016d5,156+5%

0—Dec 1844d0.00202—0.00

203+1%Feb 19107d0.141,494+57%0.14

ExpiryPutsCallsP/C

Nov 2016d750%5,156+5%0.01

Dec 1844d0—202—0.00

Feb 19107d203+1%1,494+57%0.14

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−1072.58%as filednet margin · revenue −65.00% QoQ · −73.80% YoY

Revenue$755,000−65.00%

Gross profit$755,000100.00%−65.00%

Operating income−$16M−2182.78%−14.73%

Pre-tax income−$8M+87.64%

Net income−$8M−1072.58%+87.64%

Cost of revenue$0—

Operating expenses$17M+4.32%

Tax$0—

Other income$8M+116.38%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 11:00 ET

Intraday

Event sensitivity

GDP ×1.30· ±4.4% vs ±3.4% · 19 releases

eventrelease day|move|up · n×base

GDPgross domestic product±4.4%10 of 19×1.30

PPIproducer prices±4.1%4 of 10×1.19

PCEpersonal income & outlays±4.0%12 of 19×1.16

NFPjobs report±3.8%5 of 10×1.11

FOMCrate decision±3.7%14 of 24×1.09

CPIconsumer prices±3.6%4 of 10×1.04

CPROFcorporate profits±3.5%6 of 12×1.03

Bar = avg |move| to ±5% · tick = ±3.4% avg day · ×base = |move| ÷ ±3.4% · min 6 releases

Earnings history

EPS -0.14 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.14	—
Q1 FY26	—	-0.75	—
Q3 FY25	—	-0.25	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod